MACROGENICS INC
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Nov 4, 2026 (8 days)
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Aug 17, 2026 | B. Riley Securities | maintain | Buy → Buy | — | 54% |
| Apr 20, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Apr 10, 2026 | B. Riley Securities | upgrade | Neutral → Buy | — | 54% |
| Mar 10, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Nov 3, 2025 | HC Wainwright & Co. | reiterate | Neutral → Neutral | $2 | 44% |
| Aug 15, 2025 | Leerink Partners | maintain | Outperform → Outperform | $5 | 51% |
| May 20, 2025 | B. Riley Securities | maintain | Neutral → Neutral | $3 | 54% |
| May 14, 2025 | Stifel | maintain | Hold → Hold | $5 | 53% |
| May 14, 2025 | Barclays | maintain | Overweight → Overweight | $3 | 53% |
| Mar 25, 2025 | HC Wainwright & Co. | maintain | Neutral → Neutral | $2 | 44% |
| Nov 7, 2024 | JMP Securities | downgrade | Market Outperform → Market Perform | $0 | 53% |
| Nov 6, 2024 | HC Wainwright & Co. | reiterate | Neutral → Neutral | $4 | 44% |
| Sep 18, 2024 | HC Wainwright & Co. | reiterate | Neutral → Neutral | $4 | 44% |
| Aug 21, 2024 | HC Wainwright & Co. | reiterate | Neutral → Neutral | $4 | 44% |
| Aug 15, 2024 | Citigroup | maintain | Buy → Buy | $14 | 54% |
| Aug 7, 2024 | BMO Capital | maintain | Market Perform → Market Perform | $5 | 53% |
| Aug 1, 2024 | BTIG | downgrade | Buy → Neutral | $0 | 52% |
| Aug 1, 2024 | HC Wainwright & Co. | reiterate | Neutral → Neutral | $4 | 44% |
| Jul 31, 2024 | JMP Securities | maintain | Market Outperform → Market Outperform | $8 | 53% |
| Jul 31, 2024 | Barclays | maintain | Overweight → Overweight | $8 | 53% |
| Jul 31, 2024 | Guggenheim | downgrade | Buy → Neutral | $0 | 52% |
| Jul 31, 2024 | B. Riley Securities | downgrade | Buy → Neutral | $5 | 54% |
| Jul 29, 2024 | Barclays | maintain | Overweight → Overweight | $9 | 53% |
| May 24, 2024 | BTIG | maintain | Buy → Buy | $9 | 52% |
| May 13, 2024 | HC Wainwright & Co. | maintain | Neutral → Neutral | $4 | 44% |
| May 10, 2024 | Barclays | maintain | Overweight → Overweight | $14 | 53% |
| May 10, 2024 | JMP Securities | maintain | Market Outperform → Market Outperform | $16 | 53% |
| May 10, 2024 | BMO Capital | downgrade | Outperform → Market Perform | $8 | 53% |
| May 10, 2024 | TD Cowen | downgrade | Buy → Hold | $0 | 54% |
| May 10, 2024 | Stifel | downgrade | Buy → Hold | $7 | 53% |
| Apr 9, 2024 | TD Cowen | upgrade | Hold → Buy | $0 | 54% |
| Apr 4, 2024 | JMP Securities | reiterate | — → Market Outperform | $0 | 53% |
| Mar 11, 2024 | Citigroup | maintain | Buy → Buy | $25 | 54% |
| Mar 11, 2024 | JMP Securities | maintain | Outperform → Outperform | $22 | 53% |
| Mar 11, 2024 | HC Wainwright & Co. | maintain | Neutral → Neutral | $16 | 44% |
| Mar 8, 2024 | BMO Capital | maintain | Outperform → Outperform | $24 | 53% |
| Mar 8, 2024 | Stifel | maintain | Buy → Buy | $29 | 53% |
| Mar 8, 2024 | Barclays | maintain | Overweight → Overweight | $25 | 53% |
| Mar 4, 2024 | BTIG | maintain | Buy → Buy | $24 | 52% |
| Feb 29, 2024 | Barclays | maintain | Overweight → Overweight | $23 | 53% |
| Feb 14, 2024 | HC Wainwright & Co. | downgrade | Buy → Neutral | $14 | 44% |
| Jan 24, 2024 | JMP Securities | maintain | Market Outperform → Market Outperform | $16 | 53% |
| Dec 20, 2023 | Citigroup | upgrade | Neutral → Buy | $13 | 54% |
| Nov 27, 2023 | Stifel | reiterate | Buy → Buy | $17 | 53% |
| Nov 13, 2023 | HC Wainwright & Co. | maintain | Buy → Buy | $12 | 44% |
| Nov 7, 2023 | Guggenheim | upgrade | Neutral → Buy | $12 | 52% |
| Aug 10, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $14 | 44% |
| May 11, 2023 | JMP Securities | maintain | Market Outperform → Market Outperform | $10 | 53% |
| Apr 3, 2023 | HC Wainwright & Co. | reiterate | — → Buy | $14 | 44% |
| Mar 21, 2023 | BTIG | maintain | — → Buy | $12 | 52% |
No cross-platform signals in the last 90 days